Nutritional disorders in HIV infected patients;Denutrition et infection par la VIH

Revue de Medecine Interne

Volumn 17, Issue 12, 1996, Pages 992-1002

  Rabaud, C ^a   Maignan, M ^a   Amiel, C ^a   Alfandari, S ^b   May, T ^a   Canton, P ^a  

^a CHU NANCY BRABOIS   (France)

^b CENTRE HOSPITALIER DE TOURCOING   (France)

Author keywords

aids; free radicals; HIV; wasting syndrome

Indexed keywords

ALPHA TOCOPHEROL; CYTOKINE; FREE RADICAL; GLUTAMINE; GROWTH HORMONE; ORNITHINE; ORNITHINE OXOGLUTARATE; SOMATOMEDIN C; TRACE ELEMENT; VITAMIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ENERGY METABOLISM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIPID METABOLISM; MALNUTRITION; METABOLISM; NUTRITION; NUTRITIONAL DISORDER; PATHOPHYSIOLOGY; REVIEW; PROGNOSIS;

HIV INFECTIONS; HUMANS; NUTRITION DISORDERS; PROGNOSIS;

EID: 0030456728     PISSN: 02488663     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0248-8663(97)80843-0     Document Type: Article

References (112)

1. 1 Nahlen BL, Chu SY, Nwanyanwu RL et al. HIV wasting syndrome in the United States. AIDS 1993;7:183-8
2. 2 Fleming PL, Ciessielski CA, Berkelman RL. Sex-specific differences in the prevalence of reported AIDS-indicative diagnoses, United States, 1988-1989 [Abstract]. In: VIIth International Conference on AIDS, Amsterdam, 1991
3. 3 Mohl ME, Watson RR. Nutritional effects of marijuana, heroin, cocaine and nicotine. J Am Diet Assoc 1990; 90:1261-7
4. 4 Fleming AF. Opportunistic infections in AIDS in developped and developping countries. Trans R Soc Trop Med Hyg 1990;84 (suppl 1):1-6
5. 5 Kotler DP, Gaetz HP, Lange M et al. Enteropathy associated with acquired immunodeficiency syndrome. Ann Intern Med 1984;101:421-8
6. 6 Kotler DP, Wang J, Pierson RN. Body composition studies in patients with AIDS. Am J Clin Nutr 1985;42:1255-65
7. 7 Melchior JC. Aspects métaboliques de la dénutrition au cours du sida. Nutr Clin Métab 1993;7:311-20
8. 8 Boulier A, Fricker J, Thomasset AL, Apfelbaum M. Fat free mass estimation by the two-electrode impedance methode. Am J Clin Nutr 1990;52:581-5
9. 9 Melchior JC, Gelas P, Chastang C et al. Efficacy of two months total parenteral nutrition in AIDS patients: a controlled randomized propective trial. AIDS 1996;10:379-84
10. 10 Detsky AS, Baker JP, Mendelson RA et al. Evaluation of accuracy of nutritional assessment techniques applied to hospitalized patients: methodology and comparisons. J Parenter Enteral Nutr 1984;8:153-9
11. 11 Grunfeld C, Feingold KR. Metabolic disturbance and wasting in AIDS. N Engl J Med 1992;327:329-37
12. 12 Macallan DC, Noble C, Baldwin C et al. Prospective study of patterns of weight change in stage IV HIV infection. Am J Clin Nutr 1993;58:417-24
13. 13 Romijn JA, Klein S. One more reason for weight loss in patients with AIDS. Gastroenterology 1991;101:861-2
14. 14 Melchior JC, Raguin G, Boulier A et al. REE in HIV infected patients. Comparaison between patients with and without secondary infections. Am J Clin Nutr 1993;57:614-9
15. 15 Kotler DP, Tierney AR, Wang J, Pireson RN Jr. Magnitude of body-cell-mass depletion and the timing of the death from wasting in AIDS. Am J Clin Nutr 1989;50:444-7
16. 16 Hommes MJT, Romijn JA, Endert E, Sauerwein HP. REE and substrate oxidation in HIV infected asymptomatic men: HIV affects host metabolism in the early asymptomatic stage. Am J Clin Nutr 1991;54:311-5
17. 17 Grunfeld G, Pang M, Shimizu L et al. REE, calorie intake and short term weight change in HIV infection and AIDS. Am J Clin Nutr 1992;55:455-60
18. 18 Ott M, Lemcke B, Fischer H et al. Early changes of body composition in HIV infected patients: tetrapolar body impedance analysis indicates significant malnutrition. Am J Clin Nutr 1993;57:15-9
19. 19 LoPresti JS, Fried JC, Spencer CA, Nicoloff JT. Unique alterations of thyroid hormone indices in AIDS. Ann Intern Med 1989;110:970-5
20. 20 Kotler DP, Tierney AR, Brenner SK et al. Preservation of short term energy balance in clinically stable patients with AIDS. Am J Clin Nutr 1990;51:7-13
21. 21 Coodley GO, Loveless MO, Merill TM. The HIV wasting syndrome: a review. J Acquir Immune Defic Syndr Hum Retrovirol 1994;7:681-94
22. 22 Tracey KJ, Morgello S, Koplin B et al. Metabolic effects of cachectin/tumor necrosis factor are modified by site of production. J Clin Invest 1990;86:2014-24
23. 23 Ullrich R, Zeitz M, Heise M et al. Small intestinal structure and function in patients infected with HIV: evidence for HIV-induced enteropathy. Ann Intern Med 1989;111:15-21
24. 24 Claderon E, Ramirez MA, Arrieta MI et al. Nutritional disorders in HIV disease. Prog Food Nutr Sci 1990;14:371-402
25. 25 Sharpstone D, Murray C, Ross H et al. Small bowel function in asymptomatic HIV infection [Abstract]. In: International Conference Nutrition and HIV infection, Cannes, 28-29 April 1995
26. 26 Cotte L, Peltrault C, André F et al. Intestinal permeability and malabsorption in HIV infected patients [Abstract]. In: International Conference Nutrition and HIV infection, Cannes, 28-29 April 1995
27. 27 Schwenk A, Becker K, Kremer G et al. Gastrict emptying and anorexia in AIDS patients [Abstract]. In: International Conference Nutrition and HIV infection, Cannes, 28-29 April 1995
28. 28 Hellerstein MK, Kahn J, Mudie H, Viteri F. Current approach to the treatment of human immunodeficiency virus-associated weight loss: pathophysiologic considerations and emerging management strategies. Semin Oncol 1990;17 (suppl 9):17-33
29. 29 Rabaud C, Dousset B, Candiloros H et al. Fasting insulin and C-peptide plasma levels in HIV infected patients [Abstract]. In: International Conference Nutrition and HIV infection, Cannes, 28-29 April 1995
30. 30 Hommes MJ, Romijn JA, Endert E et al. Insulin sensitivity and insulin clearance in human immunodeficiency virus-infected men. Metabolism 1991;40:651-6
31. 31 Dahn MS, Lange MP, Mitchell RA et al. Insulin production following injury and sepsis. J Trauma 1987;27:1031-6
32. 32 Heyligenber R, Romijn JA, Hommes MJ et al. Non-insulin-mediated glucose uptake in human immuodeficiency virus-infected men. Clin Sci 1993;84:209-16
33. 33 Yki-Järvigen H, Sammalkorpi K, Koivisto VA et al. Severity, duration, and mechanisms of insulin resistance during acute infection. J Clin Endocrinol Metab 1989;69:317-23
34. 34 Hommes MJT, Romijn JA, Eeftinck Schattenkerk JKM, Sauerwein HP. Basal fuel homoeostasis in symptomatic human immunodeficiency virus infection. Clin Sci 1991;80:359-65
35. 35 Leclercq P, Claude N, Micoud M, Leverve X. Metabolic dysregulation and HIV: evaluation by an induced hyperlactemia test [Abstract]. In: International Conference Nutrition and HIV infection, Cannes, 28-29 April 1995
36. 36 Deweerdt L, Gelas P, Poitevin-Later F et al. AIDS patients hypertriglyceridemia's features [Abstract]. In: International Conference Nutrition and HIV infection, Cannes, 28-29 April 1995
37. 37 Nunez EA, Christeff N. Hormone, cytokine and metabolic disturbance in HIV infection. Hormonal and metabolic disorders in HIV infection. Clin Metab Endocrinol 1994;4:803-24
38. 38 Vilcek J, Lee TH. TNF, new insights into the molecular mechanisms of its multiple action. J Biol Chem 1991;266:7313-6
39. 39 Nachiappan V, Curtiss D, Corkey BE et al. Cytokins inhibit fatty acid oxydation in isolated rat hepatocytes: synergy among TNF, IL-1 and IL-6. Shock 1994;2:123-9
40. 40 Coodley G, Girard DE. Vitamins and minerals in HIV infection. J Gen Intern Med 1991;6:472-9
41. 41 Baum MK, Shor-Posner G, Bonvehi P et al. Influence of HIV infection on vitamin status and requirements. Ann NY Acad Sci 1992;669:165-74
42. 42 Chlebowski R, Grosnevor M, Kruger S et al. Dietary intake, nutritional status, and immunologic function in patients with HIV infection [Abstract]. In: International Conference on AIDS, 1990;6:168
43. 43 Grunfeld C, Feingold KR. The role of cytokines, interferon α, and TNF in the hypertriglyceridemia and wasting of AIDS. J Nutr 1992;122:749-53
44. 44 Jones PD, Shelley L, Wakefield D. TNFα in advanced HIV infection in the absence of AIDS-related secondary infections. J Acquir Immune Defic Syndr Hum Retrovirol 1992;5:1266-71
45. 45 Hotamisligil GS, Spiegelman BM. TNFα: a key component of the obesity diabetes link. Diabetes 1994;43:1271-8
46. 46 Godfried MH, Van der Poll T, Jansen J et al. Soluble receptor for tumour necrosis factor: putative marker of disease progression in HIV infection. AIDS 1993;7:33-6
47. 47 Ockenga J, Holtmannspötter M, Gallati H et al. Circulating TNF and hypermatabolism in AIDS patients with acute disease complications [Abstract]. In: International Conference Nutrition and HIV infection, Cannes, 28-29 April 1995
48. 48 Constans J, Pellegrin I, Peuchant E et al. TNFα, IFNα and the wasting syndrome in HIV-positive patients [Abstract]. In: International Conference Nutrition and HIV infection, Cannes, 28-29 April 1995
49. 49 Constans J, Pellegrin I, Peuchant E et al. One-year predictive value of nutritional and lipidic parameters in 95 HIV-positive patients [Abstract]. In: International Conference Nutrition and HIV infection, Cannes, 28-29 April 1995
50. 50 Grunfeld C, Kotler DP. The wasting syndrome and nutritional support in AIDS. Semin Gastrointestin Dis 1991;2:25-36
51. 51 Tang AM, Graham NMH, Mc Call LD et al. Dietary micronutriment intake and risk of progression of AIDS in HIV1 infected homosexual men. Am J Epidemiol 1993;138:937-51
52. 52 Delmas-Beauvieux MC, Couchouron A, Peuchant E. Antioxydant system status in HIV-infected patients supplemented or not with selenium or β-carotene; preliminary results [Abstract]. In: International Conference Nutrition and HIV infection, Cannes, 28-29 April 1995
53. 53 Constans J, Pellegrin JC, Delmas-Beauvieux MC et al. One year supplementation of HIV-positive patients with selenium or betacarotene [Abstract]. In: Third Conference on Retrovirus and Opportunistic Infections, Washington, 28 January-1st February 1996
54. 54 Semba RV, Miotti PG, Chipangwi JD et al. Maternal vitamin A deficiency and mother to child transmission of HIV1. Lancet 1994;143:1593-7
55. 55 Peuchant E, Delmas-Beauvieux MC, Constans J et al. Preliminary results of a supplementation with β-carotene and selenium on liporeroxydation in HIV-infected patients [Abstract]. In: International Conference Nutrition and HIV infection, Cannes, 28-29 April 1995
56. 56 Delmas-Beauvieux MC, Couchouron A, Peuchant E. Antioxydant system status in HIV-infected patients supplemented or nor with selenium or β-carotene; preliminary results [Abstract]. In: International Conference Nutrition and HIV infection, Cannes, 28-29 April 1995
57. 57 Hughes WT, Prier RA et al. Protein caloric malnutrition. A host determinant for Pneumocystis carinii infection. Am J Dis Child 1974;128:44-52
58. 58 Moseson M, Zeleniuch-Jacquotte A, Belsito DV et al. The potential role of nutritional factors in the induction of immunologic abnormalities in HIV-positive homosexual men. J Acquir Immune Defic Syndr Hum Retrovirol 1989;2:235-47
59. 59 Keusch GT, Farthing MJG. Nutrition and infection. Annu Rev Nutr 1986;6:131-54
60. 60 Chandra RK. Nutrition and immunity. In: Brostoff J, Scadding GK, Male D, Roitt IM, eds. Clinical immunology, Philadelphia: Lippincott JB, London: Gower Medical Publisher, 1991
61. 61 Buttke TM, Sandstorm PA. Oxidative stress as a mediator of apoptosis. Immunol Today 1994;15:7-10
62. 62 Eck PJ, Gmunder H, Hartmann M et al. Low concentrations of acid-soluble thiols (cysteine) in the blood plasma of HIV1 infected patients. Biol Chem Hoppe-Seyler 1989;370:101-8
63. 63 Flores SC, Marecki JC, Harper KF, Mccord JM. Does the HIV TAT protein regulate host redox status? Proc Natl Acad Sci USA 1993;90:763-8
64. 64 Sandstrom PA, Buttke TM. Autocrine production of extracellular catalase prevents apoptosis of the human CEM T-cell line in serum-free medium. Proc Natl Acad Sci USA 1993;90:4708-12
65. 65 Bühl R, Holroyd KJ, Mastrangely A et al. Systemic glutathione deficiency in symptom free HIV seropositive individuals. Lancet 1989;133:1294-8
66. 66 Eck HP, Gmunder H, Hartmann M, Petzold D, Daniel V, Dröge W. Low concentrations of acid-soluble thiol (cysteine) in blood plasma of HIV-infected patients. Biol Chem Hoppe-Seyler 1989;370:101-8
67. 67 Dröge W, Eck HP, Näher H, Pekar U, Daniel V. Abnormal aminoacid concentrations in the blood of patients with acquired immunodefiency syndrome (AIDS) may contribute to the immunological defect. Biol Chem Hoppe-Seyler 1988;369:143-8
68. 68 Eck HP, Mertens T, Rosokat H et al. T4+ cell numbers are correlated with plasma glutamate and cystine levels: association of hyperglutamataemia with immunodeficiency in diseases with different actiologies. Int Immunol 1992;4:7-13
69. 69 Eck HP, Dröge W. Influence of the extracellular glutamate concentration on the intracellular cyst(e)ine concentration in macrophages and on the capacity to release cysteine. Biol Chem Hoppe-Seyler 1989;370:109-13
70. 70 Gmunder H, Eck HP, Dröge W. Low membrane transport activity for cystine in resting and mitogenically stimulated human lymphocyte preparations and human T-cells clones. Eur J Biochem 1991;201:113-7
71. 71 Christeff N, Lortholary O, Casassus P et al. Serum lipid concentrations with reference to the clinical and immunological status of HIV-infected men. Annu Rev Interne 1995;146:490-5
72. 72 Negre-Salvayre A, Lopez M, Levade T et al. Ultraviolet treated lipoproteins as a model system for the study of the biological effects of lipid peroxides on cultured cells. II. Uptake and cytotoxicity of UV-treated LDL on lymphoid cell lines. Biochim Biophys Acta 1990;1045:224-32
73. 73 Kontush A, Hübner C, Finck B, Kohlschütter A, Beisiegel U. Low density lipoprotein oxidazibility by copper correlates to its initial ubiquinol-10 and polyinsaturated fatty acid content. Febs Lett 1994;341:69
74. 74 Thomas MJ, Thornburg T, Manning J, Hooper K, Rudel LL. Fatty acid composition of low-density lipoprotein influences its susceptibility to autooxydation. Biochemistry 1994;33:1828
75. 75 Orrenius S, Mcconkey DJ, Bellomo G, Nicotera P. Role of CA in toxic cell killing. TIPS 1989;10:281-5
76. 76 Lemasters JL, Difuiseppi J, Nieminen AL, Herman B. Blebbing, free Ca++ and mitochondrial membrane potential preceding cell death in hepatocytes. Nature 1987;325:78-81
77. 77 Zazzo JF. Oligoéléments, vitamines et immunité. Nutr Clin Métab 1993;7:121-9
78. 78 Pichard C. Sida et nutrition : il faut agir durant la séropositivité. In: Journée annuelle de nutrition et de diététique, Paris, 22 octobre 1993
79. 79 Pichard C, Kyle U. Conseils de nutrition lors d'infection par le virus d'immunodéficience humaine (VIH). Méd Hyg 1992;50:589-93
80. 80 Summerbell CD. Appetite and nutrition in relation to HIV infection and AIDS. Proc Nutr Soc 1994;53:139-50
81. 81 Brüger B, Ollenschläger G, Schrappe M et al. Nutrition behaviour of malnourished HIV-infected patients and intensified oral nutritional intervention. Nutrition 1993;9:43-4
82. 82 Coodley G. Nutritional problems in HIV-infected patients. AIDS Med Rep 1991;a4:93-100
83. 83 Nelson MR, Erskine D, Hawkins DA et al. Treatment with corticosteroids: a risk factor for the development of clinical cytomegalovirus disease in AIDS. AIDS 1993;7:375-8
84. 84 Andrieu JM, Lu W, Levy R. Sustained increases in CD4 cell counts in asymptomatic human immunodeficiency virus type 1-seropositive patients treated with prednisolone for 1 year. J Infect Dis 1995;171:523-30
85. 85 Summerbell CD, Youle M, McDonald V et al. Megestrol acetate vs cyproheptadine in the treatment of weight loss associated with HIV infection. Int J STD AIDS 1992;3:278-80
86. 86 Tchekmedyian NS. Treatment of anorexia with megestrol acetate. Nutr Clin Pract 1993;8:115-8
87. 87 Gorter R, Seefried M, Volberding P. Dronabinol effects on weight in patients with HIV infection. AIDS 1992;6:127
88. 88 Fraser IS, Siddall V, Wilkins EGL. Testosterone replacement therapy in hypogonadal HIV positive men with wasting [Abstract]. In: International Conference Nutrition and HIV infection, Cannes, 28-29 April 1995
89. 89 Czernichow B, Galluser M, Hasselmann M et al. Effects of amino acids in mixtures given by enteral or parenteral route on intestinal morphology and hydrolases in rats. J Parenter Enter Nutr 1992;16:259-63
90. 90 Cones J, Beaugerie L, Lamy P et al. Nutrition entérale dans le sida compliqué d'atteinte digestive. Nutr Clin Metab 1991;5:239-46
91. 91 Gelas P, Cotte L, Deweerdt L et al. Effect of parenteral medium and long chain triglycerids on plasma lipidic pattern in HIV infected patients [Abstract]. In: International Conference Nutrition and HIV infection, Cannes, 28-29 April 1995
92. 92 Gelas P, Poitevin-Latter F, Cotte L et al. Immunological effect of parenteral medium and long chain triglycerids in HIV infected patients [Abstract]. In: International Conference Nutrition and HIV infection, Cannes, 28-29 April 1995
93. 93 Ziegler TR, Young LS, Benfell K et al. Clinical and metabolic efficacy of glutamine supplemented parenteral nutrition after bone marrow transplantation. Ann Intern Med 1992;116:821-8
94. 94 Darmaun D, Matthews DE, Bier DM. Glutamine and glutamate kinetics in humans. Am J Physiol 1986;251:E117-26
95. 95 Lundeberg S, Belfrage M, Wernerman J et al. Growth hormone improves muscle protein metabolism and whole body nitrogen economy in man during a hyponetrogenous diet. Metabolism 1991;40:315-22
96. 96 Merimee T, Rabinowitz D. A survey of growth hormone secretion and action. Metabolism 1973;22:1235-51
97. 97 Mautalen C, Smith RW. Lipolytic effects of human growth hormone in resistant obesity. J Clin Endocrinol 1965;25:495-8
98. 98 Kawabe T, Morgan CR. Multiple effects of growth hormone on insulin release from isolated pancreatic islets. Metabolism 1983;32:728-31
99. 99 Fineberg SE, Merimee T. Acute metabolic actions of human growth hormone. Diabetes 1974;23:499-504
100. 100 Rabaud C, Dousset B, Hussenet F, Amiel C, May T, Canton P. Disorders of somatotrophic axis in HIV-infected patients [Abstract]. In: Third Conference on Retroviruses and Opportunistic Infections, Washington, 28 January-1st February 1996
101. 101 Chevenne D, Porquet D. Hormone de croissance (GH) et insulin-like growth factor 1 (IGF 1) dans les états nutritionnels. Ann Biol Clin 1995;53:527-38
102. 102 Grunfeld C, Mulligan K, Hellerstein M, Schambelan M. Growth hormone therapy promotes positive nitrogen balance and weight gain in AIDS [Abstract]. In: International Conference on AIDS and STD, Firenze, 1992
103. 103 Krentz AJ, Koster FT, Crist DM et al. Beneficial anthropometric metabolic and immunologic al effects of human growth hormone in the treatment of AIDS and AIDS related complex. J Acquir Immune Defic Syndr Hum Retrovirol 1993;6:245-51
104. 104 Schambelan M, LaMarca A, Mulligan K et al. Growth hormone therapy of AIDS wasting [Abstract]. In: Tenth International Conference on AIDS, Yokohama, 7-12 August 1994
105. 105 Chevenne D. Les somatomédines. Ann Biol Clin 1991;49:69-91
106. 106 Ninh NX, Thissen JP, Maiter D et al. Reduced liver insulin-like growth factor-I gene expression in young zinc-deprived rats is associated with a decrease in lier growth hormone (GH) receptors and serum CH-binding protein. J Endocrinol 1995;144:449-56
107. 107 Lieberman SA, Butterfield GE, Harrison D, Hoffman AR. Anabolic effects of recombinant insulin-like growth factor-I in cachectic patients with the acquired immunodeficiency syndrome. J Clin Endocrinol Metab 1994;78:404-10
108. 108 Phillips LS, Vassilopoulou-Sellin R. Somatomedins (first part). N Engl J Med 1980;302:371-80
109. 109 Pell JM, Bates PC. The nutritional regulation of growth hormone action. Nutr Res Rev 1990;3:163-92
110. 110 Sattler F, Dube M, Montgomery AB et al. Phase I study of insulin-like growth factor-I in HIV [Abstract]. In: 34th Interscience Conference on Antimicrobial Agents and Chemotherapy, Orlando, 4-7 October 19942
111. 111 Koster F, Nightingale S, Gesundheit N et al. A randomized double blind placebo-controlled phase II trial of growth hormone and insulin-like growth factor I for AIDS wasting [Abstract]. In: 34th Interscience Conference on Antimicrobial Agents and Chemotherapy, Orlando, 4-7 October 1994
112. 112 Kupfer SR, Underwood LE, Baxter RC, Clemmons DR. Enhancement of the anabolic effects of growth hormone and insulin-like growth factor I by use of both agents simultaneously. J Clin Invest 1993;91:391-6